CIN-109, CIN-110, CIN-209 and CIN-210 are monotherapies and combination treatments for obesity.
GDF-15 Analog
GDF-15 / GLP-1 – Dual Agonist
CIN-109, CIN-110, CIN-209 and CIN-210 are monotherapies and combination treatments for obesity.
Gastroparesis
Deudomperidone (CIN-102) is a Dopamine 2/3 antagonist with prokinetic and antiemetic effects.
Type 1 Diabetes
An oral small molecule, adjunct therapy to insulin in patients with type 1 diabetes (T1D).
Retromer Therapeutics is developing novel medicines to treat neurodegenerative diseases.
